111
Participants
Start Date
November 29, 2016
Primary Completion Date
September 8, 2017
Study Completion Date
October 9, 2017
Commercial Formulation Etanercept
Etanercept was supplied in a single-use SureClick autoinjector as a sterile, preservative-free solution for SC injection containing 0.98 mL of 50 mg/mL etanercept in the commercial formulation.
New Formulation Etanercept
Etanercept was supplied in a single-use SureClick autoinjector as a sterile, preservative-free solution for SC injection containing 0.98 mL of 50 mg/mL etanercept in the new formulation.
Research Site, Smithtown
Research Site, Wyomissing
Research Site, South Charleston
Research Site, Orangeburg
Research Site, DeLand
Research Site, Doral
Research Site, Cutler Bay
Research Site, Miami
Research Site, Largo
Research Site, Winter Haven
Research Site, Birmingham
Research Site, Flowood
Research Site, Middleburg Heights
Research Site, Bay City
Research Site, Grand Rapids
Research Site, Skokie
Research Site, Quincy
Research Site, Kansas City
Research Site, Mesquite
Research Site, Dallas
Research Site, Houston
Research Site, The Woodlands
Research Site, El Paso
Research Site, Lomita
Research Site, Thousand Oaks
Research Site, Sherman Oaks
Research Site, El Cajon
Research Site, Bothell
Research Site, Freehold
Research Site, Ponce
Lead Sponsor
Amgen
INDUSTRY